Log in

NYSE:PRLBProto Labs Stock Price, Forecast & News

$126.35
+0.09 (+0.07 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$124.09
Now: $126.35
$127.45
50-Day Range
$75.40
MA: $97.57
$134.89
52-Week Range
$63.19
Now: $126.35
$136.85
Volume288,056 shs
Average Volume261,265 shs
Market Capitalization$3.36 billion
P/E Ratio54.94
Dividend YieldN/A
Beta1.7
Proto Labs, Inc., together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom parts for prototyping and short-run production worldwide. It utilizes injection molding, computer numerical control machining, three-dimensional (3D) printing, and sheet metal fabrication to manufacture custom parts for developers and engineers who use 3D computer-aided design software to design products across a range of end markets. The company was founded in 1999 and is headquartered in Maple Plain, Minnesota.
Read More
Proto Labs logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.1Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.02 out of 5 stars


Industry, Sector and Symbol

Industry Fabricated structural metal products
Sub-IndustryIndustrial Machinery
SectorIndustrial Products
CUSIP74371310
Phone763-479-3680

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$458.73 million
Cash Flow$3.54 per share
Book Value$22.08 per share

Profitability

Net Income$63.65 million

Miscellaneous

Employees2,535
Market Cap$3.36 billion
Next Earnings Date7/23/2020 (Estimated)
OptionableOptionable

Receive PRLB News and Ratings via Email

Sign-up to receive the latest news and ratings for PRLB and its competitors with MarketBeat's FREE daily newsletter.

Proto Labs (NYSE:PRLB) Frequently Asked Questions

How has Proto Labs' stock been impacted by COVID-19 (Coronavirus)?

Proto Labs' stock was trading at $78.36 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PRLB stock has increased by 61.2% and is now trading at $126.35. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Proto Labs?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Proto Labs in the last year. There are currently 6 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Proto Labs.

When is Proto Labs' next earnings date?

Proto Labs is scheduled to release its next quarterly earnings announcement on Thursday, July 23rd 2020. View our earnings forecast for Proto Labs.

How were Proto Labs' earnings last quarter?

Proto Labs Inc (NYSE:PRLB) posted its quarterly earnings data on Thursday, April, 30th. The industrial products company reported $0.61 EPS for the quarter, beating the Zacks' consensus estimate of $0.38 by $0.23. The industrial products company had revenue of $115.10 million for the quarter, compared to analysts' expectations of $102.36 million. Proto Labs had a net margin of 13.49% and a return on equity of 10.82%. The company's quarterly revenue was up 1.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.69 EPS. View Proto Labs' earnings history.

What price target have analysts set for PRLB?

7 Wall Street analysts have issued 1-year price targets for Proto Labs' shares. Their forecasts range from $69.00 to $145.00. On average, they expect Proto Labs' share price to reach $94.50 in the next year. This suggests that the stock has a possible downside of 25.2%. View analysts' price targets for Proto Labs.

Has Proto Labs been receiving favorable news coverage?

News articles about PRLB stock have trended neutral recently, according to InfoTrie Sentiment. The research group identifies negative and positive news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Proto Labs earned a news sentiment score of 0.3 on InfoTrie's scale. They also gave press coverage about the industrial products company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an impact on the stock's share price in the near term. View the latest news aboutProto Labs.

Are investors shorting Proto Labs?

Proto Labs saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 4,610,000 shares, a decline of 5.3% from the April 30th total of 4,870,000 shares. Based on an average daily trading volume, of 296,700 shares, the days-to-cover ratio is currently 15.5 days. Currently, 18.3% of the shares of the company are short sold. View Proto Labs' Current Options Chain.

Who are some of Proto Labs' key competitors?

What other stocks do shareholders of Proto Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Proto Labs investors own include Brainstorm Cell Therapeutics (BCLI), Netflix (NFLX), Tesla (TSLA), NVIDIA (NVDA), Starbucks (SBUX), Walt Disney (DIS), Gilead Sciences (GILD), Intel (INTC), Baidu (BIDU) and Alphabet (GOOG).

Who are Proto Labs' key executives?

Proto Labs' management team includes the following people:
  • Ms. Victoria M. Holt, Pres, CEO & Director (Age 61)
  • Mr. John A. Way, CFO & Exec. VP of Devel. (Age 46)
  • Dr. Arthur Richard Baker III, Chief Technology Officer (Age 51)
  • Mr. David M. Fein, Chief Revenue Officer (Age 50)
  • Dan Schumacher, Director of Investor Relations and FP&A

What is Proto Labs' stock symbol?

Proto Labs trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRLB."

Who are Proto Labs' major shareholders?

Proto Labs' stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (15.27%), Brown Capital Management LLC (14.22%), Riverbridge Partners LLC (5.65%), Sumitomo Mitsui Trust Holdings Inc. (4.62%), Nikko Asset Management Americas Inc. (4.62%) and Nikko Asset Management Americas Inc. (4.62%). Company insiders that own Proto Labs stock include Arthur R Baker III, John B Goodman, John Way, Robert Bodor and Sven Wehrwein. View institutional ownership trends for Proto Labs.

Which major investors are selling Proto Labs stock?

PRLB stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, TimesSquare Capital Management LLC, BlackRock Inc., Motley Fool Asset Management LLC, Disciplined Growth Investors Inc. MN, Gs Investments Inc., Arizona State Retirement System, and Principal Financial Group Inc.. View insider buying and selling activity for Proto Labs.

Which major investors are buying Proto Labs stock?

PRLB stock was bought by a variety of institutional investors in the last quarter, including Nikko Asset Management Americas Inc., Nikko Asset Management Americas Inc., Sumitomo Mitsui Trust Holdings Inc., State Street Corp, Morgan Stanley, Morgan Stanley, Aviva PLC, and Geode Capital Management LLC. View insider buying and selling activity for Proto Labs.

How do I buy shares of Proto Labs?

Shares of PRLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Proto Labs' stock price today?

One share of PRLB stock can currently be purchased for approximately $126.35.

How big of a company is Proto Labs?

Proto Labs has a market capitalization of $3.36 billion and generates $458.73 million in revenue each year. The industrial products company earns $63.65 million in net income (profit) each year or $2.35 on an earnings per share basis. Proto Labs employs 2,535 workers across the globe.

What is Proto Labs' official website?

The official website for Proto Labs is www.protolabs.com.

How can I contact Proto Labs?

Proto Labs' mailing address is 5540 Pioneer Creek Drive, Maple Plain MN, 55359. The industrial products company can be reached via phone at 763-479-3680 or via email at [email protected]

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.